CellGenuity develops biologics designed to be used as a therapeutic agent. Formulated with our patented PūrAMP process, our products are used in a wide range of surgical and non-surgical applications.
Redefining Regenerative Medicine
Click on a step in the process to learn more
AmnioAMP-MP™ is a membrane allograft that may be used as a therapeutic active barrier agent in numerous clinical applications. The membrane forms a protective covering over the wound to preserve tissue structure and biologic integrity. AmnioAMP-MP™ created with our proprietary PūrAMP Process™, offers mechanical protection and retains nutrient growth factors that are essential for signaling¹². The product undergoes active preservation of the extracellular matrix (ECM), regulatory proteins, and removal of blood contaminants via a proprietary PūrAMP Process™. AmnioAMP-MP™ is HCT/P compliant under section 361 of the Public Health Service Act according to 21 CFR Part 1271.10. This is regulated as human cell product-for homologous use only.
The amniotic membrane (or amnion) is the innermost layer of the placenta that surrounds and provides essential nutrients and immunological protection to the developing fetus. The special composition of cellular components offers mechanical protection and retains nutrient growth factors that are essential for signaling¹². The Amnionic Membrane has been used in medicine for nearly 100 years, while over the last 50 years it has grown to involve multiple fields of medicine and surgery.
- Coolen, N.A. et al. (2010). Comparison between human fetal and adult skin. Archives of Dermatological Research, 302(3), 4755.
- Rowlatt, U. (1979). Intrauterine wound healing in a 20-week fetus. Virchows Arch A Pathol Anat Histol, 381(3), 353361.